Showing results (21-30 of 50) with videos related to
Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|May 2, 2012
Wake promoting agents: search for next generation modafinil, lessons learned: part IIIDerek Dunn, Greg Hostetler, Mohamed Iqbal, et al.Biochemistry|December 22, 2004
Phosphoregulation of mixed-lineage kinase 1 activity by multiple phosphorylation in the activation loopJohn T Durkin, Beverly P Holskin, Karla K Kopec, et al.Bioorganic & Medicinal Chemistry Letters|January 5, 2002
Mixed lineage kinase activity of indolocarbazole analoguesChikara Murakata, Masami Kaneko, George Gessner, et al.Arthritis Research & Therapy|April 23, 2011
A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritisKristine L Stump, Lily D Lu, Pawel Dobrzanski, et al.Journal of Medicinal Chemistry|January 13, 2015
Design, synthesis, and biological evaluation of sulfonyl acrylonitriles as novel inhibitors of cancer metastasis and spreadYi Shen, Craig A Zificsak, Jill E Shea, et al.Chemical Research in Toxicology|October 26, 2011
2,7-Disubstituted-pyrrolotriazine kinase inhibitors with an unusually high degree of reactive metabolite formationKevin J Wells-Knecht, Gregory R Ott, Mangeng Cheng, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 2, 2011
Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2Lily D Lu, Kristine L Stump, Nate H Wallace, et al.Journal of Medicinal Chemistry|June 4, 2011
Discovery and characterization of 6-{4-[3-(R)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, irdabisant): a potent, selective histamine H3 receptor inverse agonistRobert L Hudkins, Rita Raddatz, Ming Tao, et al.Molecular Cancer Therapeutics|December 29, 2011
CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancersMangeng Cheng, Matthew R Quail, Diane E Gingrich, et al.Journal of Medicinal Chemistry|February 6, 2008
Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancerBruce D Dorsey, Mohamed Iqbal, Sankar Chatterjee, et al.Pageof 5